Logo image of VIH1.DE

VIB VERMOEGEN AG (VIH1.DE) Stock Earnings & Estimates

Europe - Frankfurt Stock Exchange - FRA:VIH1 - DE000A2YPDD0 - Common Stock

10.25 EUR
-0.05 (-0.49%)
Last: 12/10/2025, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
VIH1.DE revenue by date.VIH1.DE revenue by date.
106.749M
3.86%		99.877M
-6.44%		104.368M
4.50%		121.89M
16.79%		131.38M
7.79%
EBITDA
YoY % growth
VIH1.DE ebitda by date.VIH1.DE ebitda by date.
111.811M
1.34%		106.456M
-4.79%		213.008M
100.09%		87.924M
-58.72%		96.798M
10.09%
EBIT
YoY % growth
VIH1.DE ebit by date.VIH1.DE ebit by date.
80.357M
-0.66%		77.505M
-3.55%		73.211M
-5.54%		55.692M
-23.93%		63.852M
14.65%
Operating Margin
VIH1.DE operating margin by date.VIH1.DE operating margin by date.
75.28%77.60%70.15%45.69%48.60%
EPS
YoY % growth
VIH1.DE eps by date.VIH1.DE eps by date.
N/A
-43.54%		N/A
9.38%		N/A
-35.58%		1.94
10.47%		2.18
12.63%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
VIH1.DE Yearly EPS VS EstimatesVIH1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth		 59.829M
26.78%		%
Q4 2024
Q2Q % growth		 57.176M
22.19%		%
Q2 2024
Q2Q % growth		 47.192M
-11.10%		%
Q4 2023
Q2Q % growth		 46.793M
-56.17%		%
Q2 2023
Q2Q % growth		 53.084M
104.03%		%
Q4 2022
Q2Q % growth		 106.749M
304.40%		%
Q2 2022
Q2Q % growth		 26.018M
1.97%		%
Q1 2022
Q2Q % growth		 26.503M
7.01%		%
Q4 2021
Q2Q % growth		 26.397M
10.83%		%
Q3 2021
Q2Q % growth		 26.651M
11.13%		%
Q2 2021
Q2Q % growth		 25.516M
11.02%		%
Q1 2021
Q2Q % growth		 24.767M
5.73%		%
Q4 2020
Q2Q % growth		 23.817M
1.87%		%
Q3 2020
Q2Q % growth		 23.982M
6.44%		%
Q2 2020
Q2Q % growth		 22.984M
1.86%		%
Q1 2020
Q2Q % growth		 23.424M
4.01%		%
VIH1.DE Yearly Revenue VS EstimatesVIH1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%